Abstract

Genito-Pelvic Pain/Penetration Disorder is a common sexual disorder that affects an individual’s sexual health and overall well-being. Education is a therapeutic resource that presents several advantages, and it can potentially generate improvements both in pain and sexual functioning-related outcomes in patients suffering from this affliction. The objective of this study was to assess if a therapeutic educational program produced improvements in the different domains of the Female Sexual Function Index in participants suffering from Genito-Pelvic Pain Penetration Disorder. Participants were randomized into a group that received a face-to-face therapeutic educational program, a group that received the same program but online, or a control group. The Female Sexual Function Index was assessed, and analysis of the change in the domains for every group was performed using multiple t-tests. Improvements were found in the face-to-face intervention group, but only the “Pain” domain showed significant improvements (−1.1 points, p < 0.05). Improvements were also found in the online group, but they were only significant in the “Pain” and “Satisfaction” domains (−0.8 points, p < 0.05 for both). A therapeutic educational program improves pain-related outcomes, and it shows a positive tendency to also improve sexual functioning-related outcomes in patients suffering from Genito-Pelvic Pain/Penetration Disorder. Registration: Clinical Trials (NCT05114473).

摘要

生殖盆腔疼痛/插入障碍是一种常见的性障碍，影响个人的性健康和整体福祉。教育是一种具有多种优势的治疗资源，它可以潜在地改善患有这种疾病的患者的疼痛和性功能相关的结果。本研究的目的是评估治疗教育计划是否对患有生殖盆腔疼痛穿透障碍的参与者的女性性功能指数的不同领域产生了改善。参与者被随机分为一组接受面对面的治疗教育计划、一组接受相同的在线治疗计划或对照组。评估女性性功能指数，并使用多个 t 检验对每组的域变化进行分析。面对面干预组有所改善，但只有“疼痛”领域显示出显着改善（−1.1 分，p < 0.05）。在线组中也发现了改进，但仅在“痛苦”和“满意度”领域显着（-0.8 分，p < 0.05）。治疗性教育计划可以改善与疼痛相关的结果，并且它显示出改善患有生殖盆腔疼痛/插入障碍的患者的性功能相关结果的积极趋势。注册：临床试验（NCT05114473）。在线组中也发现了改进，但仅在“痛苦”和“满意度”领域显着（-0.8 分，p < 0.05）。治疗性教育计划可以改善与疼痛相关的结果，并且它显示出改善患有生殖盆腔疼痛/插入障碍的患者的性功能相关结果的积极趋势。注册：临床试验（NCT05114473）。在线组中也发现了改进，但仅在“痛苦”和“满意度”领域显着（-0.8 分，p < 0.05）。治疗性教育计划可以改善与疼痛相关的结果，并且它显示出改善患有生殖盆腔疼痛/插入障碍的患者的性功能相关结果的积极趋势。注册：临床试验（NCT05114473）。